Daisaku Toyoshima
- Microbiology top 10%
- Bacterial Infections and Vaccines 9
- Psychiatry and Mental health top 10%
- Epilepsy research and treatment 14
-
- Infectious Encephalopathies and Encephalitis 18
-
- Long-Term Effects of COVID-19 4
-
- Neonatal and fetal brain pathology 6
- Pharmacological Effects and Toxicity Studies 5
-
- Multiple Sclerosis Research Studies 2
-
- Electrolyte and hormonal disorders 2
- Co-authors
- Kazumoto IijimaMasahiro NishiyamaHiroaki NagaseAzusa MaruyamaHiroshi YamaguchiKandai NozuYusuke IshidaKazumi Tomioka
- Partner nations
- JapanUnited States
In The Last Decade
Daisaku Toyoshima
34 papers receiving 324 citations
Peers
Comparison fields: 5 of 50
- Microbiology 43
- Psychiatry and Mental health 96
- Infectious Diseases 107
- Neurology 67
- Pediatrics, Perinatology and Child Health 56
Countries citing papers authored by Daisaku Toyoshima
This map shows the geographic impact of Daisaku Toyoshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisaku Toyoshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisaku Toyoshima more than expected).
Fields of papers citing papers by Daisaku Toyoshima
This network shows the impact of papers produced by Daisaku Toyoshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisaku Toyoshima. The network helps show where Daisaku Toyoshima may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daisaku Toyoshima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 8 | |
| 3 | 2022 | 2 | |
| 4 | 2021 | 5 | |
| 5 | 2021 | 7 | |
| 6 | 2020 | 1 | |
| 7 | 2020 | 14 | |
| 8 | 2020 | 9 | |
| 9 | 2019 | 1 | |
| 10 | 2019 | 6 | |
| 11 | 2019 | 17 | |
| 12 | 2019 | 22 | |
| 13 | 2018 | 4 | |
| 14 | 2018 | 11 | |
| 15 | 2018 | 16 | |
| 16 | 2018 | 5 | |
| 17 | 2017 | 8 | |
| 18 | 2016 | 9 | |
| 19 | 2016 | 6 | |
| 20 | 2015 | 15 |
About Daisaku Toyoshima
Daisaku Toyoshima is a scholar working on Microbiology, Infectious Diseases and Psychiatry and Mental health, having authored 37 papers that have together received 326 indexed citations. Recurring topics across this work include Infectious Encephalopathies and Encephalitis (18 papers), Epilepsy research and treatment (14 papers), Bacterial Infections and Vaccines (9 papers), Neonatal and fetal brain pathology (6 papers), Pharmacological Effects and Toxicity Studies (5 papers), Long-Term Effects of COVID-19 (4 papers), Multiple Sclerosis Research Studies (2 papers) and Electrolyte and hormonal disorders (2 papers). The work is most often cited by research in Microbiology (43 citations), Psychiatry and Mental health (96 citations) and Infectious Diseases (107 citations). Daisaku Toyoshima has collaborated with scholars based in Japan and United States. Frequent co-authors include Kazumoto Iijima, Masahiro Nishiyama, Hiroaki Nagase, Azusa Maruyama, Hiroshi Yamaguchi, Kandai Nozu, Yusuke Ishida, Kazumi Tomioka, Hiroshi Kurosawa and Tsukasa Tanaka. Their work appears in journals such as PLoS ONE, The Journal of Pediatrics and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.